Literature DB >> 3031106

Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography.

R Woestenborghs, W Lorreyne, J Heykants.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3031106     DOI： 10.1016/0378-4347(87)80249-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  30 in total

1.  Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis.

Authors:  C Schmitt; Y Perel; J L Harousseau; S Lemerle; E Chwetzoff; J P le Moing; J C Levron
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Sputum itraconazole concentrations in cystic fibrosis patients.

Authors:  I Sermet-Gaudelus; A Lesne-Hulin; G Lenoir; E Singlas; P Berche; C Hennequin
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Limited-sampling strategy models for itraconazole and hydroxy-itraconazole based on data from a bioequivalence study.

Authors:  G Suarez-Kurtz; F A Bozza; F L Vicente; C G Ponte; C J Struchiner
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.

Authors:  J A Barone; B L Moskovitz; J Guarnieri; A E Hassell; J L Colaizzi; R H Bierman; L Jessen
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

5.  Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.

Authors:  F C Odds; F Van Gerven; A Espinel-Ingroff; M S Bartlett; M A Ghannoum; M V Lancaster; M A Pfaller; J H Rex; M G Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

Authors:  A Van Peer; R Woestenborghs; J Heykants; R Gasparini; G Gauwenbergh
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Pharmacokinetics of itraconazole following oral administration to normal volunteers.

Authors:  T C Hardin; J R Graybill; R Fetchick; R Woestenborghs; M G Rinaldi; J G Kuhn
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

8.  Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole.

Authors:  T Zimmermann; R A Yeates; H Laufen; G Pfaff; A Wildfeuer
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.

Authors:  John E Conte; Jeffrey A Golden; Juliana Kipps; Marina McIver; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Investigation of the Sterol Composition and Azole Resistance in Field Isolates of Septoria tritici.

Authors:  T Joseph-Horne; D Hollomon; N Manning; S L Kelly
Journal:  Appl Environ Microbiol       Date:  1996-01       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.